Recent research focusing on Tirzepatide at a dosage of 40mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may amplify the drug's ability to control blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully explore the lon